Open-market purchases of Lycia Therapeutics, Inc. (LYCA) stock by its own executives, directors and 10% owners — every Form 4 buy of $250K or more that SPX Lens's daily insider scan has recorded, newest first.
| Scan | Insider | Value | Type | |||
|---|---|---|---|---|---|---|
| Oct 28, 2026 | Bong Y. Koh / Venrock Healthcare Capital Partners III, L.P.10% Owner | $37.7M | New stake | |||
| Includes 1,944,444 shares at $18.00 IPO allocation price ($35.0M) + 101,016 shares open-market at $25.68–$26.84 (~$2.65M). Stock now $26.11: +45.1% vs $18 IPO, -0.6% vs open-mkt avg ~$26.28. IPO closed Oct 26; conversion of Series C/D preferred to common also occurred that day. | ||||||
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.
Open the live chartOpen in the Stocks tab© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.